Results 161 to 170 of about 230,292 (304)

Accuracy of human papillomavirus testing in detecting persistent or recurrent disease at follow‐up after conization

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
Using HPV testing and margin status alone as predictors of CIN1+ persistence/recurrence is as effective as the standard co‐test. This highlights the significance of HPV status compared to the co‐test post‐conization and indicates that HPV testing alone could be an effective follow‐up strategy for women with negative margins.
Ghina Alaref, Lone Kjeld Petersen
wiley   +1 more source

Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson   +2 more
wiley   +1 more source

Nursing students' knowledge and attitudes toward human papillomavirus vaccination and infection. [PDF]

open access: yesHum Vaccin Immunother
Mabrouk Nouh F   +13 more
europepmc   +1 more source

The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection

open access: yesBJU International, EarlyView.
Background Penile cancer is a rare malignancy, with an Australian incidence of 0.6 in 100 000 men, with a wide range of clinical presentations, from localised, curable tumours to aggressive forms with high morbidity and mortality. Epidemiological data and management guidelines for penile cancer in Australia are limited.
Henry Y.C. Pan   +11 more
wiley   +1 more source

Human Papillomavirus Vaccination Policies and Discourse on Social Media. [PDF]

open access: yesJAMA Health Forum
Zhang L, Zhang S, Liu S, Jian W.
europepmc   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Oral Health—Head and Neck Cancers: Addressing Confounding Through Negative Control and Quantitative Bias Analyses

open access: yesCommunity Dentistry and Oral Epidemiology, EarlyView.
ABSTRACT Objectives While there are plausible biological explanations for the association between oral health and head and neck cancers (HNC), existing studies have yielded conflicting results. A key concern is that these associations are influenced by mediators, unmeasured risk factors, and biases. To address this, a negative control exposure was used
P. K. Elango   +5 more
wiley   +1 more source

Finding More in Less: Precision Medicine for Pancreatic Cancer Using Residual Cytology Samples

open access: yesCytopathology, EarlyView.
The study evaluates the use of residual liquid‐based cytology (LBC) samples from pancreatic ductal adenocarcinoma (PDAC) for molecular analysis. It shows that LBC samples preserve nucleic acid quality and remain suitable for next‐generation sequencing (NGS) and MSI testing even after prolonged storage, underscoring their value when other samples are ...
Raquel Antón‐Peñalver   +17 more
wiley   +1 more source

Electronic Health Record Alerts for Early Human Papillomavirus Vaccination. [PDF]

open access: yesJAMA Netw Open
Kumra T   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy